超声引导经皮穿刺硬化治疗尾状叶肝血管瘤
Ultrasound-guided percutaneous sclerotherapy for the treatment of hepatic hemangioma in the caudate lobe
吴子臣 1徐浩 1张庆桥 1刘洪涛 1王文亮 1崔艳峰 1肖晋昌1
作者信息
- 1. 徐州医科大学附属医院介入放射科 江苏 徐州 221006
- 折叠
摘要
目的 探讨超声引导下经皮穿刺硬化治疗尾状叶肝血管瘤的疗效及安全性.方法 选取我院 16 例经超声引导下瘤内注射平阳霉素或博来霉素硬化治疗的尾状叶肝血管瘤患者的临床资料,统计瘤体缩小率、有效率、并发症.结果 16 例患者均成功治疗,随访时间 3～9 个月,瘤体平均缩小率(48.3±14.5)%,显效 7 例,有效 9 例,无效 0 例,总有效率 100%.16 个病灶共行 20 次介入治疗,术后出现腹痛 3 例,恶心、呕吐 1 例,并发症发生率 25.0%.结论 超声引导下经皮穿刺硬化治疗尾状叶肝血管瘤安全、有效.
Abstract
Objective To evaluate the efficacy and safety of ultrasound-guided percutaneous sclerotherapy in the treatment of hepatic hemangioma of the caudate lobe.Methods A retrospective analysis was conducted on the clinical data of 16 patients with hepatic caudate lobe hemangioma treated with ultrasound-guided injection of pingyangmycin or bleomycin sclerotherapy at the Affiliated Hospital of Xuzhou Medical University.Then,the tumor reduction rate,effective rate,and postoperative complica-tions were alculated.Results All 16 patients were successfully treated,with a follow-up time of 3～9 months.The average tu-mor reduction rate was(48.3±14.5)%,including that 7 cases were significantly effective,9 cases were effective,and nil was in-effective.The total effective rate was 100.0%.A total of 20 interventional treatments were performed on 16 lesions,and postop-erative abdominal pain occurred in 3 cases,nausea and vomiting in 1 case.The incidence of complications was 25.0%.Conclu-sions Ultrasound-guided percutaneous sclerotherapy is safe and effective in the treatment of hepatic caudate lobe hemangioma.
关键词
尾状叶/肝血管瘤/硬化疗法/介入性,放射学Key words
Caudate lobe/Hepatic hemangioma/Sclerotherapy/Interventional radiology引用本文复制引用
出版年
2024
NETL
NSTL
万方数据